Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed
Meemanage, Madusha, Spender, Lindsay C., Collinson, Diane, Iannetta, Joanna, Challapalli, Pranavi, Turbitt, Julie, Clark, Caroline, Baxter, Mark, Murray, Graeme, Walsh, Shaun, Miedzybrodzka, Zofia, Petty, Russell D.
Published in Cancer chemotherapy and pharmacology (01.03.2021)
Published in Cancer chemotherapy and pharmacology (01.03.2021)
Get full text
Journal Article
Epidermal growth factor receptor copy number gain (EGFR CNG) and response to gefitinib in esophageal cancer (EC): Results of a biomarker analysis of a phase III trial of gefitinib versus placebo (TRANS-COG)
Petty, Russell D., Dahle-Smith, Asa, Miedzybrodzka, Zosia, Dutton, Susan J., Murray, Graeme I, Stevenson, David, Massie, Doreen, Osbourne, Aileen, Clark, Caroline, Mansoor, Wasat, Thompson, Joyce, Harrison, Mark, Chatterjee, Anirban, Falk, Stephen, Elyan, Sean, Garcia-Alonso, Angel, Fyfe, David Walter, Chau, Ian, Collinson, Diane, Ferry, David
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article